Posted On: 09/15/2014 1:46:11 PM
Post# of 72750
$PVCT Recent Headlines
Week In Review: Luye Acquires Hanmi's Oncology Drug For $20 Million
5:57 a.m. Aug. 24, 2014
- Seeking Alpha
Provectus' Latest Developments Spark Investor Interest -- CFO/COO Culpepper Explains Why
4:06 p.m. Aug. 22, 2014
- Seeking Alpha
Provectus Biopharmaceuticals (PVCT) Q2 2014 Results - Earnings Call Transcript
9:41 p.m. Aug. 8, 2014
- Seeking Alpha
The Product Development Story Of Provectus Biopharmaceuticals
1:47 p.m. July 28, 2014
- Seeking Alpha
Provectus Admits Cash Running Low, Financing Coming Soon
9:14 a.m. July 8, 2014
- TheStreet.com
Provectus: Strong Sell On Unviable Phase III Trial, Insufficient Cash, And Fraud Allegations
1:26 p.m. June 24, 2014
- Seeking Alpha
Biotech Stock Mailbag: Vanda, Navidea, Provectus
8:00 a.m. June 13, 2014
- TheStreet.com
Provectus to hold CC to discuss PV-10 development plan
10:26 a.m. June 12, 2014
- Seeking Alpha
Provectus settles shareholder derivative lawsuit
8:12 a.m. June 12, 2014
- Seeking Alpha
Provectus Management Responds To Accusations
2:07 p.m. June 6, 2014
- Seeking Alpha
Arena Pharmaceuticals: Strong Sell On Multiple Red Flags
1:15 p.m. June 6, 2014
- Seeking Alpha
Biotech Stock Hate Mailbag: The Hostile React-o-Meter Meltdown Edition
10:32 a.m. June 6, 2014
- TheStreet.com
PV-10 Phase 2 results good enough to proceed to Phase 3
10:03 a.m. June 3, 2014
- Seeking Alpha
Provectus Is Still Overvalued: Accounting For Risk And Dilution Takes The Value Of This Company Below $0.20 Per Share
7:35 a.m. May 29, 2014
- Seeking Alpha
The Seven Deadly Sins of Biotech Investing
7:00 a.m. May 29, 2014
- TheStreet.com
Isis Shines, PTC Therapeutics Soars - Analyst Blog
11:16 a.m. May 28, 2014
- Zacks.com
Why Provectus Biopharmaceuticals (PVCT) Plummeted to a One-Year Low Today (Update)
4:15 p.m. May 27, 2014
- TheStreet.com
Provectus slammed in early trading
11:29 a.m. May 27, 2014
- Seeking Alpha
NYSE Places Provectus Listing Status Under Review
9:48 a.m. May 27, 2014
- TheStreet.com
Provectus Forges Ahead After FDA Setback
9:44 a.m. May 27, 2014
- Seeking Alpha
Provectus Pharmaceutical Analyst Coverage Continued by Small Cap Street
7:30 a.m. Sept. 8, 2014
- PR Newswire - PRF
Provectus Signs Memorandum of Understanding with Sinopharm-China
State Institute of Pharmaceutical Industry, and Sinopharm A-THINK
Pharmaceutical Co., Ltd.
9:19 a.m. Aug. 18, 2014
- BusinessWire - BZX
Provectus Biopharmaceuticals Inc. to Commence Series of Quarterly
Conference Calls on Thursday, August 7, 2014
6:01 a.m. Aug. 6, 2014
- BusinessWire - BZX
Provectus Biopharmaceuticals’ PV-10 Clinical Data on the Treatment of
Melanoma to Be Presented at European Society for Medical Oncology 2014
Congress
9:13 a.m. July 23, 2014
- BusinessWire - BZX
SHAREHOLDER ALERT: Brower Piven Encourages Investors With Losses Over $100,000 in Provectus Biopharmaceuticals, Inc. to Contact the Firm Before the Lead Plaintiff Deadline in Class Action Lawsuit -- PVCT
6:00 p.m. July 22, 2014
- GlobeNewswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Provectus Biopharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- PVCT
3:04 a.m. July 14, 2014
- GlobeNewswire
Provectus Updates Shareholders in Its Annual CEO Letter
6:01 a.m. July 8, 2014
- BusinessWire - BZX
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess Of $100,000 Investing in Provectus Biopharmaceuticals, Inc. to Contact the Firm -- PVCT
1:18 p.m. July 4, 2014
- GlobeNewswire
SHAREHOLDER ALERT: Shareholder Rights Law Firm Johnson & Weaver, LLP
Reminds Investors of Provectus Biopharmaceuticals, Inc. of Upcoming July
28, 2014 Deadline
10:34 p.m. July 3, 2014
- BusinessWire - BZX
EQUITY ALERT: The Rosen Law Firm Reminds Provectus Biopharmaceuticals, Inc. Investors of Important Class Action Deadline - PVCT
4:44 p.m. July 1, 2014
- GlobeNewswire
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT
1:58 p.m. June 27, 2014
- PR Newswire - PRF
Pharma Equities Technical Coverage -- Research on Eli Lilly, AstraZeneca, Allergan, and Provectus Biopharma
7:20 a.m. June 23, 2014
- PR Newswire - PRF
Provectus Biopharmaceuticals, Inc. to Hold Conference Call Today to
Detail Outline of Phase 3 Clinical Trial of PV-10 in Melanoma Treatment
6:00 a.m. June 19, 2014
- BusinessWire - BZX
Cohen Milstein Sellers & Toll PLLC Announces the Investigation of
Provectus Biopharmaceuticals, Inc.
5:43 p.m. June 18, 2014
- BusinessWire - BZX
Pittsburgh Law Office of Alfred G. Yates Jr., P.C. Files Class Action Lawsuit On Behalf of Shareholders of Provectus Biopharmaceuticals, Inc. (PVCT) and Announces Investigations into Aegerion Pharmaceuticals (AEGR), Aeroflex Holding (ARX), Annie's (BNNY), Altisource Residential (RESI), Fusion-io (FIO), Hertz Global Holdings (HTZ), Hittite Microwave (HITT), Medifast (MED), PetroLogistics (PDH), Ply Gem Holdings (PGEM), Protective Life (PL), Regional Management (RM), Ruby Tuesday, Inc. (RT), tw telecom (TWTC), and World Wrestling Entertainment (WWE)
4:18 p.m. June 16, 2014
- PR Newswire - PRF
Lifshitz & Miller Law Firm Announces Investigation of Annie's, Inc., Montage Technology Group Limited, OpenTable, Inc., Provectus Biopharmaceuticals, Inc., and The Bancorp Inc.
10:01 a.m. June 14, 2014
- PR Newswire - PRF
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Provectus Biopharmaceuticals, Inc. To Contact The Firm
9:32 a.m. June 14, 2014
- PR Newswire - PRF
SHAREHOLDER ALERT: Brower Piven Encourages Investors With Losses Over $100,000 in Provectus Biopharmaceuticals, Inc. to Contact the Firm Before the Lead Plaintiff Deadline in Class Action Lawsuit -- PVCT
9:45 p.m. June 13, 2014
- GlobeNewswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Provectus Biopharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- PVCT
11:00 a.m. June 13, 2014
- GlobeNewswire
Wolf Haldenstein Adler Freeman & Herz LLP Announces That a Securities Class Action Against Provectus Biopharmaceuticals, Inc. Has Been Filed in the United States District Court for the Middle District of Tennessee
7:01 p.m. June 6, 2014
- GlobeNewswire
Week In Review: Luye Acquires Hanmi's Oncology Drug For $20 Million
5:57 a.m. Aug. 24, 2014
- Seeking Alpha
Provectus' Latest Developments Spark Investor Interest -- CFO/COO Culpepper Explains Why
4:06 p.m. Aug. 22, 2014
- Seeking Alpha
Provectus Biopharmaceuticals (PVCT) Q2 2014 Results - Earnings Call Transcript
9:41 p.m. Aug. 8, 2014
- Seeking Alpha
The Product Development Story Of Provectus Biopharmaceuticals
1:47 p.m. July 28, 2014
- Seeking Alpha
Provectus Admits Cash Running Low, Financing Coming Soon
9:14 a.m. July 8, 2014
- TheStreet.com
Provectus: Strong Sell On Unviable Phase III Trial, Insufficient Cash, And Fraud Allegations
1:26 p.m. June 24, 2014
- Seeking Alpha
Biotech Stock Mailbag: Vanda, Navidea, Provectus
8:00 a.m. June 13, 2014
- TheStreet.com
Provectus to hold CC to discuss PV-10 development plan
10:26 a.m. June 12, 2014
- Seeking Alpha
Provectus settles shareholder derivative lawsuit
8:12 a.m. June 12, 2014
- Seeking Alpha
Provectus Management Responds To Accusations
2:07 p.m. June 6, 2014
- Seeking Alpha
Arena Pharmaceuticals: Strong Sell On Multiple Red Flags
1:15 p.m. June 6, 2014
- Seeking Alpha
Biotech Stock Hate Mailbag: The Hostile React-o-Meter Meltdown Edition
10:32 a.m. June 6, 2014
- TheStreet.com
PV-10 Phase 2 results good enough to proceed to Phase 3
10:03 a.m. June 3, 2014
- Seeking Alpha
Provectus Is Still Overvalued: Accounting For Risk And Dilution Takes The Value Of This Company Below $0.20 Per Share
7:35 a.m. May 29, 2014
- Seeking Alpha
The Seven Deadly Sins of Biotech Investing
7:00 a.m. May 29, 2014
- TheStreet.com
Isis Shines, PTC Therapeutics Soars - Analyst Blog
11:16 a.m. May 28, 2014
- Zacks.com
Why Provectus Biopharmaceuticals (PVCT) Plummeted to a One-Year Low Today (Update)
4:15 p.m. May 27, 2014
- TheStreet.com
Provectus slammed in early trading
11:29 a.m. May 27, 2014
- Seeking Alpha
NYSE Places Provectus Listing Status Under Review
9:48 a.m. May 27, 2014
- TheStreet.com
Provectus Forges Ahead After FDA Setback
9:44 a.m. May 27, 2014
- Seeking Alpha
Provectus Pharmaceutical Analyst Coverage Continued by Small Cap Street
7:30 a.m. Sept. 8, 2014
- PR Newswire - PRF
Provectus Signs Memorandum of Understanding with Sinopharm-China
State Institute of Pharmaceutical Industry, and Sinopharm A-THINK
Pharmaceutical Co., Ltd.
9:19 a.m. Aug. 18, 2014
- BusinessWire - BZX
Provectus Biopharmaceuticals Inc. to Commence Series of Quarterly
Conference Calls on Thursday, August 7, 2014
6:01 a.m. Aug. 6, 2014
- BusinessWire - BZX
Provectus Biopharmaceuticals’ PV-10 Clinical Data on the Treatment of
Melanoma to Be Presented at European Society for Medical Oncology 2014
Congress
9:13 a.m. July 23, 2014
- BusinessWire - BZX
SHAREHOLDER ALERT: Brower Piven Encourages Investors With Losses Over $100,000 in Provectus Biopharmaceuticals, Inc. to Contact the Firm Before the Lead Plaintiff Deadline in Class Action Lawsuit -- PVCT
6:00 p.m. July 22, 2014
- GlobeNewswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Provectus Biopharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- PVCT
3:04 a.m. July 14, 2014
- GlobeNewswire
Provectus Updates Shareholders in Its Annual CEO Letter
6:01 a.m. July 8, 2014
- BusinessWire - BZX
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess Of $100,000 Investing in Provectus Biopharmaceuticals, Inc. to Contact the Firm -- PVCT
1:18 p.m. July 4, 2014
- GlobeNewswire
SHAREHOLDER ALERT: Shareholder Rights Law Firm Johnson & Weaver, LLP
Reminds Investors of Provectus Biopharmaceuticals, Inc. of Upcoming July
28, 2014 Deadline
10:34 p.m. July 3, 2014
- BusinessWire - BZX
EQUITY ALERT: The Rosen Law Firm Reminds Provectus Biopharmaceuticals, Inc. Investors of Important Class Action Deadline - PVCT
4:44 p.m. July 1, 2014
- GlobeNewswire
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT
1:58 p.m. June 27, 2014
- PR Newswire - PRF
Pharma Equities Technical Coverage -- Research on Eli Lilly, AstraZeneca, Allergan, and Provectus Biopharma
7:20 a.m. June 23, 2014
- PR Newswire - PRF
Provectus Biopharmaceuticals, Inc. to Hold Conference Call Today to
Detail Outline of Phase 3 Clinical Trial of PV-10 in Melanoma Treatment
6:00 a.m. June 19, 2014
- BusinessWire - BZX
Cohen Milstein Sellers & Toll PLLC Announces the Investigation of
Provectus Biopharmaceuticals, Inc.
5:43 p.m. June 18, 2014
- BusinessWire - BZX
Pittsburgh Law Office of Alfred G. Yates Jr., P.C. Files Class Action Lawsuit On Behalf of Shareholders of Provectus Biopharmaceuticals, Inc. (PVCT) and Announces Investigations into Aegerion Pharmaceuticals (AEGR), Aeroflex Holding (ARX), Annie's (BNNY), Altisource Residential (RESI), Fusion-io (FIO), Hertz Global Holdings (HTZ), Hittite Microwave (HITT), Medifast (MED), PetroLogistics (PDH), Ply Gem Holdings (PGEM), Protective Life (PL), Regional Management (RM), Ruby Tuesday, Inc. (RT), tw telecom (TWTC), and World Wrestling Entertainment (WWE)
4:18 p.m. June 16, 2014
- PR Newswire - PRF
Lifshitz & Miller Law Firm Announces Investigation of Annie's, Inc., Montage Technology Group Limited, OpenTable, Inc., Provectus Biopharmaceuticals, Inc., and The Bancorp Inc.
10:01 a.m. June 14, 2014
- PR Newswire - PRF
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Provectus Biopharmaceuticals, Inc. To Contact The Firm
9:32 a.m. June 14, 2014
- PR Newswire - PRF
SHAREHOLDER ALERT: Brower Piven Encourages Investors With Losses Over $100,000 in Provectus Biopharmaceuticals, Inc. to Contact the Firm Before the Lead Plaintiff Deadline in Class Action Lawsuit -- PVCT
9:45 p.m. June 13, 2014
- GlobeNewswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Provectus Biopharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- PVCT
11:00 a.m. June 13, 2014
- GlobeNewswire
Wolf Haldenstein Adler Freeman & Herz LLP Announces That a Securities Class Action Against Provectus Biopharmaceuticals, Inc. Has Been Filed in the United States District Court for the Middle District of Tennessee
7:01 p.m. June 6, 2014
- GlobeNewswire
(0)
(0)
